quinta-feira, 5 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 17, 2026

Pulsar Helium Appoints Stephen Lange Ranzini to the Board of Directors and as Deputy Chair

View original at globenewswire.com
Pulsar Helium Appoints Stephen Lange Ranzini to the Board of Directors and as Deputy Chair THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFR…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Stephen Lange Ranzini brings deep U.S. financial market expertise, extensive institutional relationships, and a highly accomplished leadership record

    60% confidence
  • Stephen's appointment represents an important strengthening of Pulsar's senior leadership in the United States as we continue to build out a top-tier American leadership bench to support the development of our projects and capital markets profile.

    60% confidence
  • Stephen's strategic perspective and experience across banking, capital markets and financial infrastructure will provide valuable guidance as Pulsar continues advancing its assets and positioning the Company to deliver long-term value for shareholders.

    60% confidence
  • Pulsar is the first mover in both Minnesota and Greenland locations with primary helium occurrences not associated with hydrocarbon production

    60% confidence
  • Ongoing hostilities in the region have highlighted the vulnerability of global helium supply chains

    60% confidence
  • Stephen Ranzini's appointment represents an important strengthening of Pulsar's senior leadership in the United States

    60% confidence
  • Qatar accounts for approximately a third of global helium production, with exports reliant on shipping routes through the Strait of Hormuz

    60% confidence
  • UNIB has expressed intention to potentially finance up to US$12.5 million for a helium processing facility

    60% confidence
  • UNIB has already demonstrated strong support for Pulsar, holding approximately 4.99% of the Company's issued share capital, providing a US$4 million line of credit to support development activities at our Topaz project, and expressing its intention to potentially finance up to US$12.5 million for a helium processing facility.

    60% confidence
  • UNIB holds approximately 4.99% of Pulsar's issued share capital

    60% confidence
  • Stephen Ranzini has overseen University Bank's development into one of the top-performing banks in the United States

    60% confidence
  • Stephen brings deep U.S. financial market expertise, extensive institutional relationships, and a highly accomplished leadership record. As CEO of University Bank, he has overseen its development into one of the top-performing banks in the United States.

    60% confidence
  • Assisting Pulsar to complete exploration and preparations for potential development of the Topaz Project into production is a national economic and national security imperative

    60% confidence
  • Assisting Pulsar to complete the exploration program at its Topaz Project to quantify the size of the discovery and preparations for potential development of the Topaz Project into production as quickly as possible is now a national economic and national security imperative.

    60% confidence
  • Qatar accounts for approximately a third of global helium production, with exports reliant on shipping routes through the Strait of Hormuz. Ongoing hostilities in the region have highlighted the vulnerability of global helium supply chains.

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,549 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Pulsar Helium Appoints Stephen Lange Ranzini to the Board of Directors and as Deputy Chair — Source | Via News | pt.VIA.NEWS